112 related articles for article (PubMed ID: 25053622)
1. Vitamin D receptor polymorphism FokI and cancer risk: a comprehensive meta-analysis.
Gnagnarella P; Pasquali E; Serrano D; Raimondi S; Disalvatore D; Gandini S
Carcinogenesis; 2014 Sep; 35(9):1913-9. PubMed ID: 25053622
[TBL] [Abstract][Full Text] [Related]
2. BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysis.
Raimondi S; Pasquali E; Gnagnarella P; Serrano D; Disalvatore D; Johansson HA; Gandini S
Mutat Res; 2014 Nov; 769():17-34. PubMed ID: 25771722
[TBL] [Abstract][Full Text] [Related]
3. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.
Raimondi S; Johansson H; Maisonneuve P; Gandini S
Carcinogenesis; 2009 Jul; 30(7):1170-80. PubMed ID: 19403841
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor gene FokI but not TaqI, ApaI, BsmI polymorphism is associated with Hashimoto's thyroiditis: a meta-analysis.
Wang X; Cheng W; Ma Y; Zhu J
Sci Rep; 2017 Jan; 7():41540. PubMed ID: 28134349
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and skin cancer: a meta-analysis.
Gandini S; Raimondi S; Gnagnarella P; Doré JF; Maisonneuve P; Testori A
Eur J Cancer; 2009 Mar; 45(4):634-41. PubMed ID: 19008093
[TBL] [Abstract][Full Text] [Related]
6. Relation of vitamin D receptor FokI start codon polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal women in Taiwan.
Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH
Acta Obstet Gynecol Scand; 2002 Feb; 81(2):93-8. PubMed ID: 11942896
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphism of vitamin D receptor gene FokI and susceptibility of prostatic cancer: a meta-analysis].
Cao J; Li X; Hou Q; Li R; Luo R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1215-20. PubMed ID: 23281374
[TBL] [Abstract][Full Text] [Related]
8. Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration.
Ben Fradj MK; Kallel A; Gargouri MM; Chehida MA; Sallemi A; Ouanes Y; Rhouma SB; Riadh J; Feki M; Nouira Y; Kaabachi N
Tumour Biol; 2016 May; 37(5):6197-203. PubMed ID: 26615419
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: a meta-analysis.
Song GG; Lee YH
Immunol Invest; 2013; 42(7):661-72. PubMed ID: 24004063
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
Xu Y; Shibata A; McNeal JE; Stamey TA; Feldman D; Peehl DM
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):23-7. PubMed ID: 12540499
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3'-end region polymorphisms.
Ferrari S; Rizzoli R; Manen D; Slosman D; Bonjour JP
J Bone Miner Res; 1998 Jun; 13(6):925-30. PubMed ID: 9626623
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor polymorphisms (FokI, BsmI) and breast cancer risk: association replication in two case-control studies within French Canadian population.
Sinotte M; Rousseau F; Ayotte P; Dewailly E; Diorio C; Giguère Y; Bérubé S; Brisson J
Endocr Relat Cancer; 2008 Dec; 15(4):975-83. PubMed ID: 18719092
[TBL] [Abstract][Full Text] [Related]
14. Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population.
Zhang HQ; Deng A; Guo CF; Wang YX; Chen LQ; Wang YF; Wu JH; Liu JY
Arch Med Res; 2010 Jan; 41(1):46-9. PubMed ID: 20430254
[TBL] [Abstract][Full Text] [Related]
15. Association of vitamin D receptor FokI and ApaI polymorphisms with human cytomegalovirus disease in the first three months following kidney transplantation.
Zhao YG; Shi BY; Xiao L; Qian YY; Feng K; He XY; Xu XG
Chin Med J (Engl); 2012 Oct; 125(19):3500-4. PubMed ID: 23044313
[TBL] [Abstract][Full Text] [Related]
16. [Meta-analysis of relationship of vitamin D receptor gene polymorphism and tuberculosis susceptibility].
Zhao ZZ; Zhang TZ; Gao YM; Feng FM
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Oct; 32(10):748-51. PubMed ID: 20079241
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor gene BsmI and FokI polymorphisms in relation to ovarian cancer risk in the Polish population.
Mostowska A; Sajdak S; Pawlik P; Lianeri M; Jagodzinski PP
Genet Test Mol Biomarkers; 2013 Mar; 17(3):183-7. PubMed ID: 23320576
[TBL] [Abstract][Full Text] [Related]
18. Positive correlation between vitamin D receptor gene FokI polymorphism and colorectal cancer susceptibility in South-Khorasan of Iran.
Moossavi M; Parsamanesh N; Mohammadoo-Khorasani M; Moosavi M; Tavakkoli T; Fakharian T; Naseri M
J Cell Biochem; 2018 Nov; 119(10):8190-8194. PubMed ID: 29953646
[TBL] [Abstract][Full Text] [Related]
19. VDR FokI polymorphism and its potential role in the pathogenesis of gestational diabetes mellitus and its complications.
Aslani S; Hossein-Nezhad A; Mirzaei K; Maghbooli Z; Afshar AN; Karimi F
Gynecol Endocrinol; 2011 Dec; 27(12):1055-60. PubMed ID: 21663527
[TBL] [Abstract][Full Text] [Related]
20. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis.
Tang C; Chen N; Wu M; Yuan H; Du Y
Breast Cancer Res Treat; 2009 Sep; 117(2):391-9. PubMed ID: 19145484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
